GHS Cancer Institute — Greenville, North Carolina

GHS Cancer Institute is a clinical research site located in Greenville, North Carolina, United States 29615.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

GHS Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GHS Cancer Institute?

GHS Cancer Institute has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GHS Cancer Institute conducted?

GHS Cancer Institute has 1 clinical trials on record. Their work covers B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion.

Is GHS Cancer Institute accredited by Crixeo Health?

GHS Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GHS Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.